CLOs on the Move

Casana Care

www.casanacare.com

 
Casana is changing the way healthcare does business with a smart toilet seat that enables effortless, integrated, and consistent in-home health monitoring. The Heart Seat™ captures key clinical measurements, including heart rate, blood pressure, and blood oxygenation, to assist medical teams with monitoring chronic conditions beyond the four walls of the hospital. The healthcare system has been searching for this actionable intelligence for decades, and it turns out, we were sitting on a great idea all along.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Gamma Medica-Ideas (GM-I)

Gamma Medica-Ideas (GM-I), Inc is a Northridge, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

shl

shl is a Florham Park, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Veridex

Veridex is a Raritan, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Technology Imaging Services

Technology Imaging Services is a Youngstown, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tearlab

TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioners to diagnosis DED patients early in the disease process allowing for early intervention. TearLab received the CE Mark for its TearLab Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 14 countries including the US.